Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers.
Nan ZhaoRan XieXia ZhaoHong ZhaoBo JiaYingjun ZhangLin LuoZhangma HuangJing LiXingan WangHuan YanBixia HeHongming XieQingyun RenYi Min CuiPublished in: Clinical drug investigation (2019)
This study was registered at the China Food and Drug Administration (Registration numbers: 2014L02064 and 2014L02065) and at http://www.chictr.org.cn (Nos. CTR20140854, CTR20150048 and CTR20150123).